PharmaNova Fuels Business Growth with Lacerta Bio Partnership
VICTOR, N.Y., March 7, 2011 — PharmaNova, Inc. (PharmaNova) announces an agreement with Lacerta Bio, Inc. whereby Lacerta Bio’s experienced team of business development professionals will supplement PharmaNova’s team in the U.S. and U.K. to support its 2011 business growth and…
Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takeda’s DEXILANT®
FREMONT, Calif., March 2, 2011 — Handa Pharmaceuticals, LLC (“Handa”), a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug Application (“ANDA”) for Dexlansoprazole Delayed Release Capsules, 60 mg, a ge…
Replikins TransFoot and Mouth Disease (FMD) Vaccine(TM) Now Available; Highest Replikin Count in FMDV in 52 Years Found in 2009
LONDON, July 16, 2010 — BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Cou…
‘Porcupine Pflu’: A Tale of Pandemic Proportions
PORTAGE, Mich., April 12, 2010 — The rumors appear to be true! The Hen 1 Pflu Virus is indeed spreading rapidly among the porcupine population, and the Big Pfarma Company must act quickly to contain it. Porcupine Pflu (published by Trafford Publishing), by George Hughes, is a clever parallel of the…
